GILEAD SCIENCES, INC. - 10%+ Owner at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
XLO on Nasdaq
All Insider Reports
All Insider Reports

GILEAD SCIENCES, INC. - trading volume in the past year for Xilio Therapeutics, Inc.

Holdings reported by GILEAD SCIENCES, INC. for Xilio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Prefunded Warrants (right to buy) 40,384,266 $21,601,543 $0.5349 13 Feb 2026 Direct Common Stock
Series A Warrants (right to buy) 13,335,000 05 Jun 2025 Direct Common Stock
Series C Warrants (right to buy) 13,335,000 05 Jun 2025 Direct Common Stock
Series B Warrants (right to buy) 0 26 Nov 2025 Direct Common Stock

Transactions reported by GILEAD SCIENCES, INC. for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.